Diabetic Ketoacidosis

Diabetic Ketoacidosis in Pregnancy May Lead to Fetal Death

Diabetic Ketoacidosis in Pregnancy May Lead to Fetal Death

Diabetic ketoacidosis led to fatal demise, preterm birth, and neonatal intensive care unit admissions.

Guideline Implementation Decreased Pediatric Hospitalizations for DKA

Guideline Implementation Decreased Pediatric Hospitalizations for DKA

Implementation of clinical practice guidelines can reduce the length of hospitalizations among children experiencing diabetic ketoacidosis.

Normoglycemia Remission in DKA Prolonged With Metformin, Sitagliptin

Normoglycemia Remission in DKA Prolonged With Metformin, Sitagliptin

For patients with new-onset diabetic ketoacidosis and severe hyperglycemia, metformin and sitagliptin treatment after normoglycemia remission correlate with increased relapse-free survival and prolonged remission.

Computer-Guided Program May Improve Diabetic Ketoacidosis Management

Computer-Guided Program May Improve Diabetic Ketoacidosis Management

By

Compared with standard protocol, patients achieved faster resolution of acidosis and hyperglycemia.

AACE/ACE Panel Supports Continued Use of SGLT2 Inhibitors in Diabetes

AACE/ACE Panel Supports Continued Use of SGLT2 Inhibitors in Diabetes

By

Expert panel recommends continued use of SGLT2 inhibitors, as risk for DKA is low.

Reviewing Reports of Ketoacidosis With SGLT2 Inhibitors

Reviewing Reports of Ketoacidosis With SGLT2 Inhibitors

By

Jennifer N. Clements, PharmD, BPCS, CDE, BCACP, reviews some details of the reports of ketocacidosis with the use of SGLT2 inhibitors.

FDA Warns of Ketoacidosis Risk With SGLT2 Inhibitors

FDA Warns of Ketoacidosis Risk With SGLT2 Inhibitors

By

The FDA has issued a warning about the risk for ketoacidosis with the use of SGLT2 inhibitors, which are indicated for the treatment of type 2 diabetes.

Sign Up for Free e-Newsletters



CME Focus